|
MXD1 |
MAX dimerization protein 1 |
|
|
|
|
NACC2 |
NACC family member 2 |
|
|
|
|
NRIP1 |
nuclear receptor interacting protein 1 |
- SUMOylation of transcription cofactors
- Circadian Clock
- Estrogen-dependent gene expression
- NR1H2 & NR1H3 regulate gene expression linked to lipogenesis
- NR1H2 & NR1H3 regulate gene expression linked to gluconeogenesis
|
- 4-HYDROXY-N'-(4-ISOPROPYLBENZYL)BENZOHYDRAZIDE
|
|
|
PA2G4 |
proliferation-associated 2G4 |
|
|
|
|
PADI4 |
peptidyl arginine deiminase 4 |
- Chromatin modifying enzymes
|
- Citrulline
- Azithromycin
- Tetracycline
- Streptomycin
- N-[(1S)-1-(aminocarbonyl)-4-(ethanimidoylamino)butyl]benzamide
|
|
|
PHB2 |
prohibitin 2 |
|
- Capsaicin
- Rocaglamide
- Didesmethylrocaglamide
|
|
|
PHF21A |
PHD finger protein 21A |
- HDACs deacetylate histones
- Potential therapeutics for SARS
- Factors involved in megakaryocyte development and platelet production
|
|
|
|
PIAS4 |
protein inhibitor of activated STAT 4 |
- Vitamin D (calciferol) metabolism
- SUMOylation of DNA damage response and repair proteins
- SUMOylation of transcription factors
- SUMOylation of ubiquitinylation proteins
- SUMOylation of transcription cofactors
- SUMOylation of SUMOylation proteins
- SUMOylation of intracellular receptors
- SUMOylation of intracellular receptors
- SUMOylation of DNA replication proteins
- SUMOylation of immune response proteins
- Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks
- Nonhomologous End-Joining (NHEJ)
- Processing of DNA double-strand break ends
- G2/M DNA damage checkpoint
|
|
|
|
PML |
PML nuclear body scaffold |
- SUMOylation of DNA damage response and repair proteins
- SUMOylation of ubiquitinylation proteins
- Regulation of TP53 Activity through Acetylation
- Interferon gamma signaling
- Regulation of RUNX1 Expression and Activity
- Regulation of PTEN localization
- HCMV Early Events
|
|
- Acute myeloid leukemia (AML)
|
|
PPARD |
peroxisome proliferator activated receptor delta |
- Carnitine metabolism
- Regulation of pyruvate dehydrogenase (PDH) complex
- Nuclear Receptor transcription pathway
- Signaling by Retinoic Acid
|
- alpha-Linolenic acid
- Icosapent
- Troglitazone
- Valproic acid
- Treprostinil
- Rosiglitazone
- Sulindac
- Bezafibrate
- Phthalic Acid
- Heptyl glucoside
- Oleic Acid
- cis-Vaccenic acid
- Elafibranor
- KD3010
- Cardarine
- (2S)-2-{3-[({[2-fluoro-4-(trifluoromethyl)phenyl]carbonyl}amino)methyl]-4-methoxybenzyl}butanoic acid
- 2-({[3-(3,4-dihydroisoquinolin-2(1H)-ylsulfonyl)phenyl]carbonyl}amino)benzoic acid
- Indeglitazar
- {4-[3-(4-acetyl-3-hydroxy-2-propylphenoxy)propoxy]phenoxy}acetic acid
- Clinofibrate
- Glycerin
- Fenofibric acid
- Fish oil
|
|
|
PPP1R8 |
protein phosphatase 1 regulatory subunit 8 |
|
|
|
|
PTMA |
prothymosin alpha |
|
|
|
|
RBBP4 |
RB binding protein 4, chromatin remodeling factor |
- Transcription of E2F targets under negative control by DREAM complex
- Transcription of E2F targets under negative control by DREAM complex
- Transcription of E2F targets under negative control by p107 (RBL1) and p130 (RBL2) in complex with HDAC1
- G0 and Early G1
- Polo-like kinase mediated events
- PRC2 methylates histones and DNA
- Oxidative Stress Induced Senescence
- HDACs deacetylate histones
- PKMTs methylate histone lysines
- ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression
- Activation of anterior HOX genes in hindbrain development during early embryogenesis
- Deposition of new CENPA-containing nucleosomes at the centromere
- Regulation of TP53 Activity through Acetylation
- Cyclin E associated events during G1/S transition
- G1/S-Specific Transcription
- Cyclin A:Cdk2-associated events at S phase entry
- RNA Polymerase I Transcription Initiation
- Regulation of PTEN gene transcription
- Regulation of PTEN gene transcription
- Transcriptional Regulation by E2F6
- HCMV Early Events
- Potential therapeutics for SARS
|
|
|
|
RBBP7 |
RB binding protein 7, chromatin remodeling factor |
- PRC2 methylates histones and DNA
- Oxidative Stress Induced Senescence
- HDACs deacetylate histones
- PKMTs methylate histone lysines
- HATs acetylate histones
- RMTs methylate histone arginines
- ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression
- Activation of anterior HOX genes in hindbrain development during early embryogenesis
- Deposition of new CENPA-containing nucleosomes at the centromere
- Regulation of TP53 Activity through Acetylation
- RNA Polymerase I Transcription Initiation
- Regulation of PTEN gene transcription
- Regulation of PTEN gene transcription
- Neddylation
- Transcriptional Regulation by E2F6
- HCMV Early Events
- Potential therapeutics for SARS
|
|
|
|
RBP1 |
retinol binding protein 1 |
- Retinoid cycle disease events
- The canonical retinoid cycle in rods (twilight vision)
- Retinoid metabolism and transport
|
|
|
|
RCOR1 |
REST corepressor 1 |
- HDACs deacetylate histones
- Regulation of PTEN gene transcription
- Potential therapeutics for SARS
- Factors involved in megakaryocyte development and platelet production
|
|
|
|
RELA |
RELA proto-oncogene, NF-kB subunit |
- Activation of NF-kappaB in B cells
- RIP-mediated NFkB activation via ZBP1
- Regulated proteolysis of p75NTR
- Downstream TCR signaling
- NF-kB is activated and signals survival
- Senescence-Associated Secretory Phenotype (SASP)
- FCERI mediated NF-kB activation
- DEx/H-box helicases activate type I IFN and inflammatory cytokines production
- PKMTs methylate histone lysines
- Transcriptional regulation of white adipocyte differentiation
- TAK1 activates NFkB by phosphorylation and activation of IKKs complex
- Interleukin-1 processing
- SUMOylation of immune response proteins
- IkBA variant leads to EDA-ID
- Dectin-1 mediated noncanonical NF-kB signaling
- CLEC7A (Dectin-1) signaling
- CD209 (DC-SIGN) signaling
- CLEC7A/inflammasome pathway
- The NLRP3 inflammasome
- Transcriptional Regulation by VENTX
- Interleukin-1 signaling
- TRAF6 mediated NF-kB activation
- Purinergic signaling in leishmaniasis infection
|
|
|
|
RFX5 |
regulatory factor X5 |
|
|
- Bare lymphocyte syndrome (BLS) type2
- Combined immunodeficiencies (CIDs), including the following nine diseases: X-linked hyper IgM syndrome; CD40 deficiency hyper IgM syndrome; Purine nucleoside phosphorylase (PNP) deficiency; Omenn syndrome; MHC deficiency (HLA-class I); MHC deficiency (HLA-class II); Zap-70 deficiency; p56 Lck deficiency; CD8 deficiency
|
|
RUNX3 |
RUNX family transcription factor 3 |
- Binding of TCF/LEF:CTNNB1 to target gene promoters
- RUNX3 regulates CDKN1A transcription
- RUNX3 regulates NOTCH signaling
- Regulation of RUNX3 expression and activity
- RUNX3 Regulates Immune Response and Cell Migration
- RUNX3 Regulates Immune Response and Cell Migration
- RUNX3 regulates WNT signaling
- RUNX3 regulates YAP1-mediated transcription
- RUNX3 regulates RUNX1-mediated transcription
- RUNX3 regulates p14-ARF
- RUNX3 regulates BCL2L11 (BIM) transcription
|
|
|
|
SALL1 |
spalt like transcription factor 1 |
- POU5F1 (OCT4), SOX2, NANOG activate genes related to proliferation
|
|
|